Paasa Logo
Jazz Pharmaceuticals plc logo
JAZZNASDAQMarket closedOpens 9:30am ET

Jazz Pharmaceuticals plc

$222.45Last updated
-$8.74 (3.78%)Past day
Timezone

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is trading at $222.45, about ₹21,540 at today's USD/INR rate, as of 8 Oct 2026, 4:00 PM ET, down 3.78% today. Indian residents can buy Jazz Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$228.01
Previous close:$231.19
Volume:1.20M

Today's low

$214.78

Today's high

$229.33

52 week low

$128.80

52 week high

$266.38

JAZZ opened at $228.01, closed previously at $231.19, and has traded between $128.80 and $266.38 over the past 52 weeks.

About

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

Country
IE
CEO
Renee D. Gala
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
2,890
Sector
Healthcare
IPO date
01/06/2007

Key statistics

Avg. volume

873.84K

Market cap

$13.97B

P/E Ratio

14.63

Price-to-sales ratio

3.04

Enterprise value

$14.40B

Free cash flow yield

11.05%

Debt-to-equity ratio

0.92

Return on equity

-8.25%

ROIC

1.22%

Beta

0.32

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$4.27B

Earnings per share

-$5.84

Free cash flow

$1.15B

Net profit margin

20.45%

Gross margin

84.67%

EBITDA

$262.76M

Revenue growth

4.88%

Similar securities

This is not an investment recommendation

How to buy Jazz Pharmaceuticals from India

Indian residents can buy Jazz Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Jazz Pharmaceuticals from India

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Jazz Pharmaceuticals and place an order

    Find Jazz Pharmaceuticals by name or by its ticker, JAZZ, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Jazz Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Jazz Pharmaceuticals position in USD and INR. Jazz Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Trading and taxes when buying Jazz Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneJazz Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

FAQs

Can Indian residents buy Jazz Pharmaceuticals stock?

Yes. Jazz Pharmaceuticals (JAZZ) has been listed on NASDAQ since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Jazz Pharmaceuticals share cost in rupees?

One Jazz Pharmaceuticals share is $222.45 — about ₹21,540 at a USD/INR rate of 96.83 on 7 Oct 2026. Both the Jazz Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Jazz Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy Jazz Pharmaceuticals with less than the price of one share?

Yes. A whole Jazz Pharmaceuticals share is $222.45, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.

How are gains on Jazz Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Jazz Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Jazz Pharmaceuticals pay a dividend?

No. Jazz Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Jazz Pharmaceuticals from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is Jazz Pharmaceuticals a United States company, and does that change how it is taxed?

Jazz Pharmaceuticals trades on NASDAQ in US dollars, but the company is domiciled in Ireland. Jazz Pharmaceuticals trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare Jazz Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Jazz Pharmaceuticals holding, its cost and its closing value.

How do I sell Jazz Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.